Okamoto S, Ikeda M, Morise T, Miyamori I, Takeda R
Second Department of Internal Medicine, School of Medicine, Kanazawa University, Ishikawa, Japan.
J Endocrinol Invest. 1991 May;14(5):357-60. doi: 10.1007/BF03349083.
Endogenous digital-like substance (DLS) is increased in patients with essential hypertension and is hypothesized to play a role in the pathogenesis of high blood pressure. Whether an increase in DLS in diabetic patients with hypertension is associated with a family history of hypertension or diabetic nephropathy was investigated. Plasma DLS was measured as Na(+)-K(+)-ATPase inhibitory activity (ATPI) in 100 Type 2 diabetic patients. Ouabain was used as a standard of Na-K-ATPase inhibition. Diabetic patients with hypertension demonstrated a greater ATPI level than normotensive diabetic patients (p less than 0.05). In patients with hypertension groups, the positive family history group had a higher ATPI level than the negative family history group (p less than 0.01). Microalbuminuria was not correlated with the ATPI level in diabetic patients. These results suggest that ATPI might play a role in the pathogenesis of hereditary hypertension associated with diabetes mellitus, but not have etiologic significance in diabetic nephropathy.
内源性类洋地黄物质(DLS)在原发性高血压患者中升高,据推测其在高血压发病机制中起作用。本研究调查了高血压糖尿病患者中DLS升高是否与高血压家族史或糖尿病肾病相关。在100例2型糖尿病患者中,将血浆DLS测定为钠钾ATP酶抑制活性(ATPI)。哇巴因用作钠钾ATP酶抑制的标准。高血压糖尿病患者的ATPI水平高于血压正常的糖尿病患者(p<0.05)。在高血压组患者中,阳性家族史组的ATPI水平高于阴性家族史组(p<0.01)。糖尿病患者的微量白蛋白尿与ATPI水平无关。这些结果表明,ATPI可能在糖尿病相关的遗传性高血压发病机制中起作用,但对糖尿病肾病没有病因学意义。